Crossroads Strategies, LLC
Crossroads Strategies, LLC filed a Q4 report for Haleon US Holdings LLC on January 19, 2026, reporting $50,000 in lobbying income.
Lobbying for Haleon US Holdings LLC · consumer health care company
Issues related to healthcare and payment for over-the-counter drugs; General education of over-the-counter switches, including reauthorization of the Over-the-Counter Monograph Drug User Fee Act and policies impacting a Nonprescription Drug Product with an Additional Condition for Nonprescription Use; H.R.4273/S.2292, Over-the-Counter Monograph Drug User Fee Amendments; FY2026 Continuing Appropriations and Extensions Act (H.R.5371/P.L.119-37).
Issues related to coverage of over-the-counter products with FSAs and HSAs.
Policies impacting access to over-the-counter products; FY2026 Financial Services and General Government Appropriations Act process (H.R.5166/S.3290).
Policies impacting the supply chain and manufacturing of over-the-counter pharmaceutical products including tariffs.